Gastrointestinal (GI) Cancer Risk Evaluation Program


The Abramson Cancer Center of the University of Pennsylvania is a national leader in the field of gastrointestinal cancer genetics. Penn Medicine was one of the first in the country to establish a Gastrointestinal (GI) Cancer Risk Evaluation Program.

If concerned about the risk of gastrointestinal cancer, it's important to have the best team of experts.

The GI Cancer Risk Evaluation Program at the Abramson Cancer Center has specialists nationally recognized for their expertise in cancer and genetics and can provide information, care and support to help patients throughout the entire risk evaluation program.

Penn's GI Cancer Risk team is familiar with and able to provide clinical, genetic and research services for people with concerns about the following conditions:

  • Hereditary and familial colon cancer: Diseases including familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome predisposes people to develop colon polyps, which are benign growths and colon cancer. An early diagnosis combined with appropriate treatment and follow-up can dramatically lower the chances of developing colon cancer. In addition, other conditions that are evaluated include: MYH associated polyposis (MAP), Peutz-Jeghers syndrome and Juvenile Polypsis.
  • Hereditary and familial pancreatic cancer: This includes those with BRCA2, p16INK4a or SKT11 mutations as well as those with family history.
  • Barrett's esophagus
  • Esophageal cancer
  • Stomach cancer: This includes those with the E-cadherin mutation
  • Gastrointestinal sarcomas

Who is at Risk?

Program
People with one close relative, such as a parent or sibling, who has colon or another type of gastrointestinal cancer, may be at an increased risk for cancer. Patients already diagnosed with a gastrointestinal cancer and may be concerned about cancer risk in other family members.

Those who may have an increased risk of an inherited gastrointestinal cancer include:

  • People with multiple relatives with some type of cancer
  • People who have been diagnosed colon polyps or colon cancer or another gastrointestinal cancer at an early age
  • People who have multiple relatives with colon polyps
  • People who have relatives with different forms of cancer
  • People with multiple, different cancers

About the Program

If a patient, or a relative of a patient is concerned about their risk for developing gastrointestinal cancer, The Gastrointestinal Cancer Risk Evaluation Program can help answer such questions as:

  • What is my level of risk for developing gastrointestinal cancer?
  • How can I protect myself?
  • What about the risk to my family members?
  • Would testing for inherited forms of cancer be helpful?

For more information about the program, or to download an application for the program, visit Penn Medicine’s Gastroenterology division website.

To learn about what sets us apart, visit:


Kristi Elder

Kristi Elder lived cancer free for 12 years after treatments in her mid-20s for a rare cancer. While coming to Penn for routine follow-up, a staff member recognized that Kristi could benefit from our survivorship program. In Kristi's first visit with o

Watch CANPrevent Colorectal Cancer Conference to learn about your risk for developing colorectal cancer.

Watch Focus on Gastrointestinal Cancers Conference - Get information on the latest advances in gastrointestinal cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.

Watch Focus On Pancreatic Cancer Conference - Get information on the latest advances in pancreatic cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.

Watch the Focus On Neuroendocrine Tumors Conference

NBC10 Colorectal Cancer Awareness Month
Video with Dr. Gregory Ginsberg

OncoLink's" The Basics" -- Learn basic information about different gastrointestinal cancers.

 

OncoLink - Advances in Colorectal Cancer Screening. Read OncoLink's brown bag chat transcript.

Clinical Briefing: Management of Neuroendocrine Tumors

Abramson Cancer Centers Gastrointestinal Cancer Program is conducting exciting, innovation research entitled "The Mechanisms of Esophageal Carcinogenesis." This important project will define underlying mechanisms in the development of esophageal cancer that will lead to new ways to diagnose and treat this cancer. Find out more...



Clinical Trials

Clinical trials are studies to find new ways to prevent, detect and treat cancer. The purpose of each clinical trial is to answer a specific question. Our physicians carefully design these studies to find new ways to improve care and quality of life ...


Learn More